
Journal of the Chemical Society. Perkin transactions I p. 213 - 217 (1996)
Update date:2022-08-03
Topics:
Hitotsuyanagi, Yukio
Lee, Suguru
Ito, Izumi
Kondo, Kazuyuki
Takeya, Koichi
Yamagishi, Takehiro
Nagate, Takatoshi
Itokawa, Hideji
The effective conversion of RA-VII 1 into the naturally less-accessible RA-II 4 has been devised through boron tribromide bis-O-demethylation and successive selective partial O-methylation using diazo(trimethylsilyl)methane. The O-triflate 11 prepared from RA-II 4 was subjected to cross-coupling reaction with alkylstannanes to produce analogues 12, 13 and 15, while compounds 13 and 15 were later converted into analogues 14 and 16, respectively. Analogues 12-16 showed antitumour activity against P-388 leukaemia both in vitro and in vivo.
View MoreWUHU HUAHAI BIOLOGY ENGINEERING CO LTD
Contact:+86-553-3836920
Address:7/F NO.82 LAODONG ROAD WUHU CHINA
JiangXi Keyuan Biopharma Co., LTD.
Contact:+86-563-6833666
Address:Guangde Fine Chemical Zone, Anhui Province, China
Shandong Bolode Bio-Technology Co., LTD
Contact:+86-0531-58966870
Address:136 Jingyi Road,Huaiyin District,Jinan,Shandong,China
website:http://www.cheminn.com/
Contact:86-531-67875205
Address:No.9-2,South of Shanda Road, Jinan ,China
Hubei Lingsheng Pharmaceuticals Co., Ltd.
Contact:+86-0710-3538058
Address:Xiangyang City Xiangcheng Economic Development Zone, Hubei Province
Doi:10.1016/S0040-4020(97)00368-2
(1997)Doi:10.1021/jo951894m
(1996)Doi:10.1080/00397919608086753
(1996)Doi:10.1246/cl.1997.875
(1997)Doi:10.1021/ic9508076
(1996)Doi:10.1016/0040-4039(96)00062-7
(1996)